Population issues in clinical trials.

  title={Population issues in clinical trials.},
  author={Zab Mosenifar},
  journal={Proceedings of the American Thoracic Society},
  volume={4 2},
  pages={185-7; discussion 187-8}
  • Zab Mosenifar
  • Published 2007 in Proceedings of the American Thoracic Society
Inclusion of underrepresented groups in clinical trials is important for several reasons. Age, sex, race, genetic factors, concomitant use of other medications, and comorbid conditions all may play pivotal roles in response to a drug or intervention. Despite the legislation for broader inclusion of underrepresented groups in clinical trials (via the… CONTINUE READING